The mitochondrial KATP channel and cardioprotection

Annals of Thoracic Surgery

Volumn 75, Issue 2, 2003, Pages

  McCully, James D ^a,b   Levitsky, Sidney ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; POTASSIUM CHANNEL; POTASSIUM CHANNEL AFFECTING AGENT; POTASSIUM CHANNEL BLOCKING AGENT;

CONFERENCE PAPER; DRUG POTENCY; DRUG SELECTIVITY; HEART MITOCHONDRION; HEART MUSCLE FIBER MEMBRANE; HEART PROTECTION; HEART SURGERY; MEMBRANE POTENTIAL; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARDIAC SURGICAL PROCEDURES; DIAZOXIDE; HEART ARREST, INDUCED; HEMODYNAMIC PROCESSES; HUMANS; MITOCHONDRIA, HEART; MYOCARDIAL REPERFUSION INJURY; POTASSIUM CHANNELS; VASODILATOR AGENTS;

EID: 0037317019     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)04689-1     Document Type: Conference Paper

References (67)

1. Katz AM. Effects of ischemia on contractile processes of heart muscle. Am J Cardiol 1972;32:456-60.
2. Sternbergh W, Brunsting LA, Abd-Elfattah AS, Wechsler AS. Basal metabolic energy requirements of polarized and depolarized arrest in rat heart. Am J Physiol 1989;256:H846-51.
3. Wright R, Levitsky S, Rao K, Holland C, Feinberg H. Potassium cardioplegia. Arch Surg 1978;113:976-80.
4. Tsukube T, McCully JD, Faulk E, et al. Magnesium cardioplegia reduces cytosolic and nuclear calcium and DNA fragmentation in the senescent myocardium. Ann Thorac Surg 1994;58:1005-11.
5. Tsukube T, McCully JD, Metz RM, Cook CU, Levitsky S. Amelioration of ischemic calcium overload correlates with high energy phosphates in the senescent myocardium. Am J Physiol Heart Circ Physiol 1997;42:H418-27.
6. Faulk EA, McCully JD, Tsukube T, Hadlow NC, Krukenkamp IB, Levitsky S. Myocardial mitochondrial calcium accumulation modulates nuclear calcium accumulation and DNA fragmentation. Ann Thorac Surg 1995;60:338-44.
7. Faulk EA, McCully JD, Hadlow NC, et al. Magnesium cardioplegia enhances mRNA levels and the maximal velocity of cytochrome oxidase I in the senescent myocardium during global ischemia. Circulation 1995;92:405-12.
8. Shiroshi MS. Myocardial protection - the rebirth of potassium based cardioplegia. Tex Heart Inst J 1999;26:71-86.
9. Hearse DJ. Cardioplegia the protection of the myocardium during open heart surgery: a review. J Physiol 1980;76:751-68.
10. Hearse DJ, Garlick PB, Humphrey SM. Ischemic contracture of the myocardium. Mechanism and prevention. Am J Cardiol 1977;39:986-93.
11. McCully JD, Tsukube T, Ataka K, Krukenkamp IB, Feinberg H, Levitsky S. Myocardial cytosolic calcium accumulation during ischemia/reperfusion: the effects of aging and cardioplegia. J Cardiothorac Surg 1994;9:449-52.
12. Matsuda H, McCully JD, Levitsky S. Developmental differences in cytosolic calcium accumulation associated with global ischemia: evidence for differential intracellular calcium channel receptor activity. Circulation 1997;96(Suppl II):II-233-9.
13. McCully JD, Levitsky S. Mechanisms of in vitro cardioprotective action of magnesium on the aging heart. Magnes Res 1997;7:313-28.
14. Toyoda Y, Levitsky S, McCully JD. Opening of mitochondrial ATP-sensitive potassium channels enhances cardioplegic protection. Ann Thorac Surg 2001;71:1281-9.
15. Toyoda Y, Khan S, Chen WM, Parker RA, Levitsky S, McCully JD. Effects of NHE-1 inhibition on cardioprotection and impact on protection by K/Mg cardioplegia. Ann Thorac Surg 2001;72:836-43.
16. McCully JD, Ueumatsu M, Levitsky S. Adenosine enhanced ischemic preconditioning provides myocardial protection equal to that of cold blood cardioplegia. Ann Thorac Surg 1999;67:699-704.
17. Wakiyama H, Cowan DB, Toyoda Y, Federman M, Levitsky S, McCully JD. Selective opening of mitochondrial ATP-sensitive potassium channels during cardiopulmonary bypass decreases apoptosis and necrosis in a model of acute myocardial infarction. Eur J Cardio-thorac Surg 2002;21:424-33.
18. Matsuda H, McCully JD, Levitsky S. Inhibition of RNA transcription modulates magnesium supplemented potassium cardioplegia protection. Ann Thorac Surg 2000;70:2107-12.
19. Zingman LV, Hodgson DM, Bienengraeber M, et al. Tandem function of nucleotide binding domains confers competence to sulfonylurea receptor in gating ATP-sensitive K+ channels. J Biol Chem 2002;277:14206-10.
20. Gross GJ, Fryer RM. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ Res 1999;84:973-9.
21. Liu Y, Sato T, O'Rourke B, Marbαn E. Mitochondrial ATP-dependent potassium channels. Circulation 1998;97:2463-9.
22. Deutsch N, Klitzner TS, Lamp ST, Weiss JN. Activation of cardiac ATP-sensitive K+ current during hypoxia: correlation with tissue ATP levels. Am J Physiol Heart Circ Physiol 1991;261:H671-6.
23. Downey JM, Liu GS, Thornton JD. Adenosine and the anti-infarct effects of preconditioning. Cardiovasc Res 1993;27:3-8.
24. Grover GJ. Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol 1997;75:309-15.
25. + channels. News Physiol Sci 1998;13:31-7.
26. + channel in insulin-secreting pancreatic β-cells. J Mol Endocrinol 1999;22:113-23.
27. Noma A. ATP-regulated K+ channels in cardiac muscle. Nature 1983;305:147-8.
28. Inagaki N, Seino S. ATP-sensitive potassium channels: structures, functions, and pathophysiology. Jpn J Physiol 1998;48:397-412.
29. Babenko AP, Aguilar-Bryan L, Bryan J. A view of sur/KIR6.X, KATP channels. Ann Rev Physiol 1998;60:667-87.
30. Yokoshiki H, Sunagawa M, Seki T, Sperelakis N. ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol 1998;274:C25-37.
31. Inoue I, Nagase H, Kishi K, Higuti T. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature 1991;352:244-7.
32. Paucek P, Mironova G, Mahdi F, Beavis A, Woldegiorgis G, Garlid K. Reconstitution and partial purification of the glibenclamide-sensitive ATP-dependent K+ channel from rat liver and beef heart mitochondria. J Biol Chem 1992;267:26062-9.
33. Liu Y, Ren G, O'Rourke B, Marbán E, Seharaseyon J. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels. Mol Pharmacol 2001;59:225-30.
34. Seharaseyon J, Ohler A, Sasaki N, et al. Molecular composition of mitochondrial ATP-sensitive potassium channels probed by viral Kir gene transfer. J Mol Cell Cardiol 2000;32:1923-30.
35. Bajgar R, Seetharaman S, Kowaltowski AJ, Garlid KD, Paucek P. Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain. J Biol Chem 2001;276:33369-74.
36. Garlid KD, Paucek P. The mitochondrial potassium cycle. IUBMB Life 2001;52:153-8.
37. ATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol 1997;75:309-15.
38. + channels: possible mechanism of cardio-protection. Circ Res 1997;81:1072-82.
39. ATP channel as a receptor for potassium channel openers. J Biol Chem 1996;271:8796-9.
40. ATP channels in ischemic cardioprotection. Circulation 2000;101:2418-23.
41. ATP channels in adenosine enhanced ischemic preconditioning. Am J Phys Heart Circ Physiol 2000;279:H2694-703.
42. Dorman BH, Hebbar L, Zellner JL, et al. ATP-sensitive potassium channel activation before cardioplegia. Effects on ventricular and myocyte function. Circulation 1998;98:II-176-83.
43. Fagbemi SO, Chi L, Lucchesi BR. Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents. J Cardiovasc Pharmacol 1993;21:709-19.
44. Ducko CT, Stephenson ER Jr, Jayawant AM, Vigilance DW, Damiano RJ Jr. Potassium channel openers: are they effective as pretreatment or additives to cardioplegia? Ann Thorac Surg 2000;69:1363-8.
45. Jayawant AM, Lawton JS, Hsia PW, Damiano RJ Jr. Hyperpolarized cardioplegic arrest with nicorandil: advantages over other potassium channel openers. Circulation 1997; 96(Suppl):II-240-6.
46. Maskal SL, Cohen NM, Hsia PW, Wechsler AS, Damiano RJ Jr. Hyperpolarized cardiac arrest with a potassium-channel opener, aprikalim. J Thorac Cardiovasc Surg 1995;110:1083-95.
47. Monti F, Iwashiro K, Picard S, et al. Adenosine triphosphate-dependent potassium channel modulation and cardioplegia-induced protection of human atrial muscle in an in vitro model of myocardial stunning. J Thorac Cardiovasc Surg 2000;119:842-8.
48. Sellers EM, Koch-Weser J. Binding of diazoxide and other benzothiadiazines to human albumin. Biochem Pharmacol 1974;23:553-66.
49. ATP channels in cardioprotection. Basic Res Cardiol 2000;95:280-4.
50. Holmuhamedov EL, Jovanovic S, Dzeja PP, Jovanovic A, Terzic A. Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am J Physiol 1998;275:H1567-76.
51. Holmuhamedov EL, Wang L, Terzic A. ATP-sensitive K + channel openers prevent Ca 2+ overload in rat cardiac mitochondria. J Physiol (Lond) 1999;519:347-60.
52. Korge P, Honda HM, Weiss JN. Regulation of the mitochondrial permeability transition by matrix Ca 2+ and voltage during anoxia/reoxygenation. Am J Physiol 2001;280:C517-26.
53. O'Rourke B. Myocardial KATP channels in preconditioning. Circ Res 2000;87:845-55.
54. Pain T, Yang XM, Critz SD, et al. Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals. Circ Res 2000;87:460-6.
55. Forbes RA, Steenbergen C, Murphy E. Diazoxide-induced cardioprotection requires signaling through a redoxsensitive mechanism. Circ Res 2001;88:802-9.
56. Akao M, Ohler A, O'Rourke B, Marban E. Mitochondrial ATP-sensitive potassium channels inhibit apoptosis by oxidative stress in cardiac cells. Circ Res 2001;88:1267-75.
57. Laclau MN, Boudina S, Thambo JB, et al. Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase. J Mol Cell Cardiol 2001;33:947-56.
58. Hackenbrock CR, Chazotte B, Gupte SS. The random collision model and a critical assessment of diffusion and collision in mitochondrial electron transport. J Bioenerg Biomembr 1986;18:331-68.
59. Kowaltowski AJ, Seetharaman S, Paucek P, Garlid KD. Bioenergetic consequences of opening the ATP-sensitive K(+) channel of heart mitochondria. Am J Physiol 2001;280:H649-57.
60. Beavis AD, Brannan RD, Garlid KD. Swelling and contraction of the mitochondrial matrix. I. A structural interpretation of the relationship between light scattering and matrix volume. J Biol Chem 1985;260:13424-33.
61. Dos Santos P, Kowaltowski AJ, Laclau MN, et al. Mechanisms by which opening the mitochondrial ATP-sensitive K(+) channel protects the ischemic heart. Am J Physiol Heart Circ Physiol 2002;283:H284-95.
62. Fukuse T, Hirata T, Omasa M, Wada H. Effect of adenosine triphosphate-sensitive potassium channel openers on lung preservation. Am J Respir Crit Care Med 2002;165:1511-5.
63. Kevelaitis E, Oubenaissa A, Peynet J, Mouas C, Menasché P. Preconditioning by mitochondrial ATP-sensitive potassium channel, openers: an effective approach for improving the preservation of heart transplants. Circulation 1999; 100(Suppl):II345-50.
64. Feng J, Li H, Rosenkranz ER. Diazoxide protects the rabbit heart following cardioplegic ischemia. Mol Cell Biochem 2002;233:133-8.
65. Grover GJ, D'Alonzo AJ, Garlid KD, et al. Pharmacologic characterization of BMS-191095; a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity. J Pharmacol Exp Ther 2001;297:1184-92.
66. Rovnyak GC, Ahmed SZ, Ding CZ, et al. Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(N-aryl)-substituted benzopyran derivatives with high selectivity. J Med Chem 1997;40:24-34.
67. Neckar J, Szarszoi O, Koten L, et al. Effects of mitochondrial K(ATP) modulators on cardioprotection induced by chronic high altitude hypoxia in rats. Cardiovasc Res 2002;55:567-75.